Literature DB >> 16251431

Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases.

Eric Charpantier1, Andreas Wiesner, Kyung-Hye Huh, Roch Ogier, Jean-Charles Hoda, Geraldine Allaman, Mario Raggenbass, Dominik Feuerbach, Daniel Bertrand, Christian Fuhrer.   

Abstract

Nicotine, a component of tobacco, is highly addictive but possesses beneficial properties such as cognitive improvements and memory maintenance. Involved in these processes is the neuronal nicotinic acetylcholine receptor (nAChR) alpha7, whose activation triggers depolarization, intracellular signaling cascades, and synaptic plasticity underlying addiction and cognition. It is therefore important to investigate intracellular mechanisms by which a cell regulates alpha7 nAChR activity. We have examined the role of phosphorylation by combining molecular biology, biochemistry, and electrophysiology in SH-SY5Y neuroblastoma cells, Xenopus oocytes, rat hippocampal interneurons, and neurons from the supraoptic nucleus, and we found tyrosine phosphorylation of alpha7 nAChRs. Tyrosine kinase inhibition by genistein decreased alpha7 nAChR phosphorylation but strongly increased acetylcholine-evoked currents, whereas tyrosine phosphatase inhibition by pervanadate produced opposite effects. Src-family kinases (SFKs) directly interacted with the cytoplasmic loop of alpha7 nAChRs and phosphorylated the receptors at the plasma membrane. SFK inhibition by PP2 [4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine] or SU6656 (2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide) increased alpha7 nAChR-mediated responses, whereas expression of active Src reduced alpha7 nAChR activity. Mutant alpha7 nAChRs lacking cytoplasmic loop tyrosine residues because of alanine replacement of Tyr-386 and Tyr-442 were more active than wild-type receptors and insensitive to kinase or phosphatase inhibition. Because the amount of surface alpha7 receptors was not affected by kinase or phosphatase inhibitors, these data show that functional properties of alpha7 nAChRs depend on the tyrosine phosphorylation status of the receptor and are the result of a balance between SFKs and tyrosine phosphatases. These findings reveal novel regulatory mechanisms that may help to understand nicotinic receptor-dependent plasticity, addiction, and pathology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251431      PMCID: PMC6725579          DOI: 10.1523/JNEUROSCI.3497-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

Review 1.  Synaptic neurotransmitter-gated receptors.

Authors:  Trevor G Smart; Pierre Paoletti
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

Review 2.  Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor.

Authors:  Wen-Yan Cui; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

Review 3.  Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation.

Authors:  Carlos A Báez-Pagán; Manuel Delgado-Vélez; José A Lasalde-Dominicci
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-14       Impact factor: 4.147

4.  Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.

Authors:  Herman J Ng; Edward R Whittemore; Minhtam B Tran; Derk J Hogenkamp; Ron S Broide; Timothy B Johnstone; Lijun Zheng; Karen E Stevens; Kelvin W Gee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

Review 5.  Cholinergic control of inflammation.

Authors:  M Rosas-Ballina; K J Tracey
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

6.  EphB receptors co-distribute with a nicotinic receptor subtype and regulate nicotinic downstream signaling in neurons.

Authors:  Zhaoping Liu; William G Conroy; Tamara M Stawicki; Qiang Nai; Robert A Neff; Darwin K Berg
Journal:  Mol Cell Neurosci       Date:  2008-03-18       Impact factor: 4.314

7.  AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation.

Authors:  Dominik Feuerbach; Nicole Pezous; Markus Weiss; Kasra Shakeri-Nejad; Kurt Lingenhoehl; Daniel Hoyer; Konstanze Hurth; Graeme Bilbe; Christopher R Pryce; Kevin McAllister; Frederique Chaperon; Klaus Kucher; Donald Johns; Thomas Blaettler; Cristina Lopez Lopez
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 8.  Looking below the surface of nicotinic acetylcholine receptors.

Authors:  Clare Stokes; Millet Treinin; Roger L Papke
Journal:  Trends Pharmacol Sci       Date:  2015-06-08       Impact factor: 14.819

9.  cAMP-dependent protein kinase inhibits α7 nicotinic receptor activity in layer 1 cortical interneurons through activation of D1/D5 dopamine receptors.

Authors:  Pragya Komal; Jasem Estakhr; Melad Kamran; Anthony Renda; Raad Nashmi
Journal:  J Physiol       Date:  2015-06-25       Impact factor: 5.182

10.  A novel nicotinic mechanism underlies β-amyloid-induced neuronal hyperexcitation.

Authors:  Qiang Liu; Xitao Xie; Ronald J Lukas; Paul A St John; Jie Wu
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.